|
Evolutec is
an international biopharmaceutical company that successfully floated
on AIM on August 2, 2004. The Company employs the tick’s “stealth
technology” against human diseases. An array of molecules
are present in the saliva of ticks that suppress mammalian immune
responses and have evolved over millions of years to enable ticks
to take blood from their hosts. These molecules offer the potential
of treating human diseases that are caused by over-responsiveness
of the immune system. Evolutec is developing these novel tick-derived
products for the treatment of allergic, inflammatory and autoimmune
diseases and their lead product is in phase II clinical development.
Objectives
 |
Communicate
the capabilities, product development and current positioning
to potential investors/shareholders and commercial partners |
| |
Develop
a new, more dynamic corporate style which would form the basis
of all future communication tools and work with the corporate
logo type |
| |
Maintain
an association with the tick as its technology source, but demonstrate
that the Company has products that are advancing through the
clinical stages |
| |
Design
the site to allow for future expansion as the Company grows,
ensuring website can meet the needs of a plc. |
Methods
| |
Creation
of a corporate colour palette that formed the basis of all designed
visual content including diagrams and illustrations etc. |
| |
Photography
was used as a key element of the website design to establish
a distinctive look. The photos chosen communicate both Evolutec’s
technology - “the tick”, and it’s products
- “biopharmaceuticals” |
| |
A modular
grid structure was utilised to prioritise and section information
to make it readily accessible to different audiences |
| |
First draft
of text was copywritten from information in the investors' prospectus |
Results
| |
The
day Evolutec announced its intention to float coincided with
the launch of the new website |
| |
On August
2, 2004, the day Evolutec floated on AIM, the website received
over 50,000 visitors |
Web address:
www.evolutec.co.uk
|
